Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

What is Protein A?

Protein A is a 42KDa cell surface protein which is found on the cell walls of 90% of Staphylococcus aureus bacterial strains. It is encoded for by the polymorphic X-region of the SpA gene, and functions as an immunoglobulin-binding protein, characteristically

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Protein A is a 42KDa cell surface protein which is found on the cell walls of 90% of Staphylococcus aureus bacterial strains. It is encoded for by the polymorphic X-region of the SpA gene, and functions as an immunoglobulin-binding protein, characteristically being able to bind with the ‘Fc-region’ of IgG (immunoglobulin G). This protein is an integral part of the evolution of Staphylococcus aureus, as it can simplifies bacterial transmission, and allows it to take hold of the host in a shorter space of time.

What does Protein A do?

The main function of Protein A within the cell wall of S. aureus bacteria involves the host’s immune system. It is a virulence determinant (a molecule which determines how easily a pathogen can cause disease in a host) and plays a role in suppressing host B-cell responses - which therefore assists in preventing the host immune response from damaging the bacteria. Protein A also binds to the ‘Fc region’ of IgG, and also to the ‘Fab regions’ of B-cells – triggering processes which ultimately block opsonophagocytosis, and kills the B-cells that it comes in contact with. An experiment performed in 2015 showed that guinea pigs which were purposely infected with the S. aureus bacterial strain called SpAKKAA showed increased anti-S. aureus immune response. Immunisation with the SpAKKAA strain can be used to elicit the production of neutralizing antibodies – enabling the guinea pigs to develop sufficient protective immunity.

How does Protein A affect humans?

S. aureus is a Gram-positive and cocci-shaped bacterium, meaning that it appears purple with ‘Gram stain’, and these bacterial are seen as clusters of small, spherical cells. S. aureus is a part of the human microbiome – mostly being found on the surface of the skin and all mucous membranes (e.g. eyes, mouth and ears). They are opportunistic bacteria, meaning that if a break in the skin occurs, or if the host becomes immunodeficient in some way, S. aureus can eventually cause an infection. When S. aureus does infect a human host, it may result in a variety of different diseases, but very commonly it causes recurrent soft tissue and skin infections. These infections have become more prevalent in recent years, mainly as nosocomial forms, as methicillin-resistant strains of S. aureus (MRSA) have evolved in hospitals across the western world. In humans, protein A (once it is released into the extra-cellular environment) can bind with the ‘Fc’ fragment of immunoglobulin G (IgG) and has been observed to be antiphagocytic in vitro - which is consistent with its IgG binding abilities, as binding to IgG can interfere with bacterial attachment by the antibody. This means that it can prevent itself from being destroyed by certain elements of the human immune system (as was also similarly observed in the guinea pig experiment from 2013). S. aureus infections, such as endocarditis, are usually treated with a strong course of antibiotics. Protein A can therefore function slightly differently in different species, but always has the same goal: it interferes with the host’s B-cells within their immune system to prevent S. aureus from being phagocytosed and destroyed. This is an ideal adaptation, and when coupled with the known propensity of S. aureus to be more easily transmitted than other coagulase-positive bacteria, it indicates faster and more widespread bacterial transmission.

Sources

  • Staphylococcus aureus Protein A Promotes Immune Suppression
  • Protein A Suppresses Immune Responses during Staphylococcus aureus Bloodstream Infection in Guinea Pigs
  • Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice.
  • Evaluation of recent Protein A stationary phase innovations for capture of biotherapeutics
  • Effect of Protein A on Staphylococcal Opsonization
  • Significance of Protein A Production by Staphylococci
  • Molecular typing of methicillin-resistant Staphylococcus aureus on the basis of protein A gene polymorphism
  • Staphylococcus Aureus

Last Updated: Feb 26, 2019

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01How long does it take for vitamins to work?

Biologically, vitamins are absorbed within hours and have instant metabolic effects, such as antioxidants that protect cells or compounds that are building blocks for making hormones. But, many factors impact their efficiency and could keep your body from fully absorbing them. Absorption and effects depend on each individual and what combination of vitamins they take. Gender, age, digestive health, medical conditions, and diet all play a role. One helpful practice to detect deficiencies is to look for the symptoms deficiencies create. Then, look for improvement in your symptoms with supplement intake. You are unlikely to see or feel changes if you do not lack nutrients. If you are chronically tired or see signs of unhealthy nails, hair, or skin, supplements may help as these are indicators that you are lacking nutrients in your diet. If you are unsure, your doctor can order tests to check for deficiencies in your blood.

Source: www.medicinenet.com ↗
02Where do Lipids Come From?

Excess carbohydrates in the diet are converted into triglycerides, which involves the synthesis of fatty acids from acetyl-CoA in a process known as lipogenesis, and takes place in the endoplasmic reticulum. In animals and fungi, a single multi-functional protein handles most of these processes, while bacteria utilize multiple separate enzymes. Some types of unsaturated fatty acids cannot be synthesized in mammalian cells, and so must be consumed as part of the diet, such as omega-3. Acetyl-CoA is also involved in the mevalonate pathway, responsible for producing a wide range of isoprenoids, which include important lipids such as cholesterol and steroid hormones.

Source: www.news-medical.net ↗
03You have worked across the full drug development pipeline. How has that experience shaped your view of where AI can have the greatest impact in drug safety discovery?

Having worked across different parts of the discovery process, I think broad exposure changes the way you think. I have developed quantum chemistry, artificial intelligence (AI) and machine learning (ML) methods in research settings, but I have also had the chance to apply them in real discovery environments for materials and pharmaceuticals. That experience has shown me how different parts of the discovery pipeline interact, what their motivations are, and how they communicate. AI and ML have been used in early discovery for many years, but the biggest recent shift is in areas dominated by human processes and communication. Computers can now interact directly with human language and analytical images, opening new applications such as AI research assistants and AI-assisted dossier drafting. That means AI can start to work more collaboratively with scientists, although expert oversight and guardrails remain essential. In nonclinical safety, I think the biggest impact will be AI working alongside safety scientists to unearth key data, connect safety science with earlier discovery and later clinical work, and help process, predict, and summarize important outcomes. That could help safety science integrate more tightly with design, make, and test cycles in discovery, while also interfacing earlier with clinical science. Save a Copy of This Exclusive Interview by Downloading the Free PDF

Source: www.news-medical.net ↗
04Could you discuss any ongoing or future research projects that you are particularly excited about in the field of axon biology and sncRNAs?

Certainly. We're keenly exploring extracellular vesicles as mediums for cells to communicate. These cell made vesicles often carry microRNAs and other non-coding RNAs, presenting a unique avenue to understand how neurons modulate their environment, which is especially interesting in neurological conditions. We are exploring extracellular vesicles as these tools with which cells can communicate and transfer gene expression patterns. And we're looking at, for example, how early life brain tumours such as medulloblastoma can impact neuron development and activity and how this can affect later life pain processing and neurological conditions. This has been possible via funding from the Medical Research Foundation, which supported a big collaboration between the labs of Gareth Hathway, Beth Coyle, Vicky James, Anna Grabowska and myself in Nottingham.

Source: www.news-medical.net ↗
05How does the zwitterionic form of an amino acid relate to the pI?

When the pH is exactly at the pKa value, a buffer arises in which the deprotonated and protonated amino acids exist in equilibrium. For example, when the pH = 2.34 (pKa of glycine), the solution comprises of 50% neutral molecules in which the carboxyl is deprotonated, and 50% positive molecules where the carboxyl is protonated. This pH produces the carboxyl buffer zone. If the pH s increased to that of the pKa of the amino group (9.60), another buffer is produced where there is an equilibration between the protonated neutral zwitterion and the deprotonated negative amino acid. The isoelectric point can, therefore, be approximated by averaging the two pKa values. More complex amino acids have more than two pKa values due to the presence of additional pKa values for their side chains.

Source: www.news-medical.net ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →